Yüklüyor......
Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
OBJECTIVES: Allergic bronchopulmonary aspergillosis (ABPA) can accelerate lung function decline in patients with cystic fibrosis (CF). Antifungal medication can be used in addition to systemic corticosteroid treatment. PATIENTS AND METHODS: We evaluated Aspergillus-specific IgE and the use of therap...
Kaydedildi:
| Yayımlandı: | J Antimicrob Chemother |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6664389/ https://ncbi.nlm.nih.gov/pubmed/30805605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz075 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|